Society Letters

SDP Reauthorization Letter to Leadership

September 15, 2020

To:The Honorable Nancy Pelosi, The Honorable Mitch McConnell, The Honorable Kevin McCarthy, The Honorable Chuck Schumer

"Since 2019, SDP has experienced four short-term extensions lasting between several weeks and several months. Under normal circumstances, short-term extensions have not been beneficial for SDP. Short-term funding jeopardizes the viability of SDP resulting in interruptions on important research and cuts in services. However, a short-term extension of SDP during the current COVID-19 pandemic would be even more harmful. As a result of the pandemic, SDPI has reported that nearly 1 in 5 programs have had to furlough employees, including healthcare workers, over the past six months. Roughly 1 in 4 SDPI programs have also reported delaying essential purchases of medical equipment to treat and monitor diabetes due to funding uncertainty. SDPI programs would likely face additional budget constraints under a short-term extension. Funding for SDP Type 1 is needed to understand the impact that COVID-19 has had on people with diabetes. Research has shown that people with type 1 diabetes were 3.5 times more likely to die in the hospital from COVID-19 than those without diabetes. Further research is needed to understand why people with type 1 diabetes are at a greater risk when diagnosed with COVID-19."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!